We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$275M
AUM Growth
-$6.14M
Cap. Flow
-$12.2M
Cap. Flow %
-4.43%
Top 10 Hldgs %
46.48%
Holding
168
New
21
Increased
21
Reduced
21
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPC icon
76
W.P. Carey
WPC
$16.9B
$438K 0.16%
6,126
MSFT icon
77
Microsoft
MSFT
$2.93T
$395K 0.14%
1,400
IMVT icon
78
Immunovant
IMVT
$8.27B
$370K 0.13%
42,600
-54,694
-56% -$493K
GMED icon
79
Globus Medical
GMED
$10.5B
$355K 0.13%
4,631
IBER
80
DELISTED
Ibere Pharmaceuticals
IBER
$349K 0.13%
36,000
CAG icon
81
Conagra Brands
CAG
$6.83B
$339K 0.12%
10,000
META icon
82
Meta Platforms (Facebook)
META
$1.64T
$336K 0.12%
990
PSQH.WS icon
83
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.58M
$307K 0.11%
+26,666
New +$19.3K
AAPL icon
84
Apple
AAPL
$4.9T
$297K 0.11%
2,100
QTEKW
85
DELISTED
QualTek Services Inc. Warrant
QTEKW
$288K 0.1%
25,000
BRSL
86
Brightstar Lottery PLC
BRSL
$1.97B
$276K 0.1%
10,500
-97,000
-90% -$2.06M
MSACW
87
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$256K 0.09%
22,222
FSBW icon
88
FS Bancorp
FSBW
$327M
$253K 0.09%
7,300
+146
+2% +$5.01K
TARA icon
89
Protara Therapeutics
TARA
$230M
$252K 0.09%
36,479
+315
+0.9% +$2.46K
WARR
90
DELISTED
Warrior Technologies Acquisition Company
WARR
$245K 0.09%
25,000
CDXS icon
91
Codexis
CDXS
$204M
$233K 0.08%
+10,000
New +$237K
CRSP icon
92
CRISPR Therapeutics
CRSP
$4.71B
$224K 0.08%
2,000
PSTX
93
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$216K 0.08%
29,566
IBER.WS
94
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$207K 0.08%
18,000
JMIA
95
Jumia Technologies
JMIA
$805M
$182K 0.07%
9,800
CTIC
96
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$177K 0.06%
60,000
AGAC
97
DELISTED
African Gold Acquisition Corp
AGAC
$175K 0.06%
18,000
-50,000
-74% -$483K
SEEL
98
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$174K 0.06%
19
SIOX
99
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$174K 0.06%
80,000
XLRN
100
DELISTED
Acceleron Pharma
XLRN
$172K 0.06%
+1,000
New +$131K

Similar funds

David M. Knott's Q3 2021 Portfolio in Review

As of Q3 2021, David M. Knott held 168 positions worth $275M, down 2.2% from $281M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

David M. Knott withdrew a net $12.2M in Q3 2021, closing 18 positions and reducing 21 holdings. Its most notable exit was Coliseum Acquisition Corp. Unit, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Materials.

Against the trend, David M. Knott opened a new position in Coliseum Acquisition Corp. Class A Ordinary Share worth $9.56M.

  • David M. Knott's largest Q3 2021 buy was Coliseum Acquisition Corp. Class A Ordinary Share: 984,835 shares worth $9.56M.
  • David M. Knott added most to Calumet Specialty Products in Q3 2021, an estimated $2.85M increase.
  • David M. Knott's biggest Q3 2021 reduction was FS KKR Capital, cutting an estimated $4.31M.
  • David M. Knott fully exited Coliseum Acquisition Corp. Unit in Q3 2021, selling an estimated $14.7M.
  • David M. Knott's ten largest holdings make up 46% of its $275M portfolio in Q3 2021.
  • David M. Knott opened 21 new positions and closed 18 in Q3 2021.
  • David M. Knott's portfolio value fell 2.2% quarter-over-quarter to $275M.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.